Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.
4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products. We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.
Company Differentiators:
• Fully integrated clinical-phase company with internal manufacturing
• Demonstrated ability to move rapidly from idea to IND
• Five candidate products in the clinic and two declared pre-clinical programs
• Robust technology and IP foundation, including our TVE and manufacturing platforms
• Initial product safety and efficacy data substantiates the value of our platforms
• Opportunities to expand to other indications and modalities within genetic medicine
GENERAL SUMMARY
Support the advancement of 4D-150 by collaborating with key thought leaders, opinion leaders, and influencers in Retina care at both local and national levels. These individuals will bring exceptional clinical expertise and work closely with designated thought leaders to foster advocacy for nAMD treatment and the transformative potential of gene therapy, specifically 4D-150. They will establish partnerships with leading physician groups and societies, helping to build momentum within the field. Additionally, this team will identify educational needs and opportunities, ensuring these insights are effectively integrated into our broader corporate strategies.
RESPONSIBILITIES:
- Develop and implement a strategic plan to support the advancement of 4D-150 through engagement with key thought leaders and influencers in Retina care.
- Exhibit strong clinical expertise in disease states and product-specific knowledge.
- Gather and share valuable customer insights and feedback to inform go-to-market strategies and brand development.
- Represent the company in customer interactions with a deep understanding of the 4D-150 program and the transformative potential of gene therapy for nAMD.
- Facilitate collaboration and knowledge-sharing among internal stakeholders to align efforts and drive success.
- Build relationships with leadership from regional and national retina societies, as well as ophthalmic and optometric organizations, to identify partnership opportunities for 4DMT.
- Uphold the highest standards of integrity by ensuring full compliance with all regulations and company policies.
QUALIFICATIONS:
- Bachelor’s degree in a science or business-related field.
Experience:
- A minimum of 8 years of experience in the pharmaceutical or biotechnology industry.
- Previous team leadership experience is preferred.
- Direct experience working with customers in Retina segments, with an established network of thought leader relationships strongly desired.
Skills:
- Strong clinical expertise, particularly in specialty pharmaceutical or biopharmaceutical settings.
- Demonstrated leadership capabilities and the ability to excel in cross-functional roles.
- Exceptional communication, presentation, and organizational skills.
Travel: 80%
Base salary compensation range: $183,000 - $221,000
Please note, the base salary compensation range and actual salary offered to the final candidate depends on various factors: candidate’s geographical location, relevant work experience, skills, and years of experience.
4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.
Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities
What We Do
4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.
We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together:
- Dare to Cure
- Break Boundaries
- Beyond Yourself
- Prepare & Executive Relentlessly
